Viewing Study NCT00922792


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-05 @ 11:05 AM
Study NCT ID: NCT00922792
Status: COMPLETED
Last Update Posted: 2016-05-13
First Post: 2009-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congenital Bleeding Disorder View
None Haemophilia A View
None Haemophilia B View
Keywords: